CVS Health Co. (NYSE:CVS) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of CVS Health Co. (NYSE:CVS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nineteen ratings firms that are presently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $69.12.

CVS has been the topic of a number of research analyst reports. TD Cowen upped their target price on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, November 25th. UBS Group raised their target price on shares of CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research note on Thursday, November 7th. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 8th. Piper Sandler lowered their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research report on Monday, November 25th. Finally, Royal Bank of Canada cut their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research report on Friday, November 15th.

Institutional Trading of CVS Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Garland Capital Management Inc. grew its holdings in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock worth $3,591,000 after acquiring an additional 160 shares during the period. Sound Income Strategies LLC grew its stake in CVS Health by 7.2% in the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock worth $151,000 after purchasing an additional 162 shares during the period. Hexagon Capital Partners LLC raised its holdings in CVS Health by 3.5% in the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock worth $331,000 after purchasing an additional 178 shares in the last quarter. Bruce G. Allen Investments LLC lifted its position in CVS Health by 13.1% during the third quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator's stock valued at $106,000 after buying an additional 195 shares during the period. Finally, HHM Wealth Advisors LLC boosted its holdings in shares of CVS Health by 11.9% during the 2nd quarter. HHM Wealth Advisors LLC now owns 1,886 shares of the pharmacy operator's stock valued at $111,000 after buying an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Price Performance

Shares of CVS traded up $0.11 during midday trading on Wednesday, hitting $44.25. 5,922,735 shares of the company traded hands, compared to its average volume of 11,650,967. The stock has a 50-day moving average of $55.33 and a 200-day moving average of $57.98. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health has a one year low of $43.56 and a one year high of $83.25. The firm has a market cap of $55.68 billion, a P/E ratio of 11.23, a PEG ratio of 0.85 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $2.21 EPS. As a group, sell-side analysts predict that CVS Health will post 5.32 EPS for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.